Related Experiment Video
Updated: May 3, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
Hexavalent vaccines for immunization in paediatric age
S Esposito1, C Tagliabue, S Bosis
1Paediatric High Intensity Care Unit, Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Combined hexavalent vaccines simplify immunization schedules, reducing missed vaccinations and healthcare costs. This review examines the immunogenicity, efficacy, and safety of these combination vaccines against diphtheria, tetanus, pertussis, hepatitis B, polio, and Hib.
Area of Science:
- Immunology
- Vaccinology
- Public Health
Background:
- Increasing vaccine availability can complicate immunization schedules, potentially reducing coverage.
- Combined vaccines offer benefits like fewer patient visits, reduced injection complications, and lower costs.
- Combined vaccines minimize the risk of delayed or missed vaccinations.
Purpose of the Study:
- To review the immunogenicity, efficacy, safety, and tolerability of hexavalent vaccines.
- To discuss commercially available and developing hexavalent vaccine preparations.
Main Methods:
- Literature review of studies on hexavalent vaccines.
- Analysis of immunogenicity, efficacy, safety, and tolerability data.
- Comparison of available and developmental hexavalent vaccine formulations.
Main Results:
- Hexavalent vaccines combine antigens for diphtheria, tetanus, acellular pertussis (DTaP), hepatitis B (HBsAg), poliomyelitis (P1, P2, P3), and Haemophilus influenzae type B (Hib).
- Data on immunogenicity, efficacy, safety, and tolerability of various hexavalent vaccines are presented.
- Both available and developmental hexavalent vaccines are assessed.
Conclusions:
- Hexavalent vaccines present a viable strategy to improve vaccination coverage and adherence.
- These combination vaccines demonstrate favorable immunogenicity, efficacy, and safety profiles.
- Further development and implementation of hexavalent vaccines are supported by current evidence.
Related Concept Videos
Vaccinations
Vaccines
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing: Infants and Children
Vaccine Production

